COMPANY INFO
Brellium Inc. is a private healthcare technology company founded in 2021 (some sources mention 2023) by Zach Rosen, Alex Le Tu, Max Katzman, and Henry Kasa. The company has approximately 29 employees and operates an AI-powered clinical compliance platform that audits medical charts in real-time to ensure clinical and billing standards are met, helping healthcare organizations optimize compliance and reduce costs. Their website is www.brellium.com and they operate primarily in the healthcare software and enterprise software industries.
Brellium Inc. is a private healthcare technology company founded in 2021 by Zach Rosen, Alex Le Tu, Max Katzman, and Henry Kasa. Operating primarily out of New York, United States, Brellium develops an AI-powered clinical compliance platform that audits medical charts in real-time, helping healthcare organizations optimize compliance and reduce costs. With approximately 29 employees, the company focuses on serving the hospitals and health care industry by ensuring clinical and billing standards are met efficiently and accurately.
Brellium Inc. has demonstrated a focused and strategic approach to fundraising. Since its inception, the company has raised a total of $16.7 million through a single Series A funding round. This milestone reflects Brellium's ability to attract a strong syndicate of top-tier investors, leveraging their support to scale its AI-driven compliance platform, grow its team, and accelerate its product roadmap. The company's funding strategy emphasizes robust partnerships with venture capital firms and notable industry leaders to drive its growth and technological advancement in healthcare compliance.
This Series A funding round was utilized to grow Brellium's team, accelerate the development of its product roadmap, and further advance its AI-powered clinical compliance platform for healthcare organizations. The funds are directed towards innovation, expanding operational capabilities, and supporting the increasing demand for real-time clinical and billing compliance solutions.
First Round Capital is a leading early-stage venture capital firm that played a pivotal role in Brellium Inc.'s Series A round, providing both capital and strategic guidance to help the company scale its AI compliance platform in the healthcare sector.
Left Lane Capital is a growth equity firm specializing in technology-driven companies. As a lead investor in Brellium's Series A, Left Lane Capital supports the company's growth initiatives and product expansion.
Menlo Ventures, one of the foremost venture capital firms in the technology space, also contributed as a lead investor. Their involvement brings significant industry expertise and access to a broad network and resources.
Digital Health Venture Partners invests exclusively in digital health startups. Their participation in Brellium's funding round underscores investor confidence in the company's mission to streamline healthcare compliance through technology.
Kearny Jackson is an early-stage venture capital firm with a focus on supporting innovative technology companies. Their investment strengthens Brellium's position in the healthcare software landscape.
Necessary Ventures provides capital and strategic guidance for companies solving important global challenges. Their backing reflects belief in Brellium's potential impact on healthcare compliance.
Andrew Adams is the CEO of Headway and a respected healthcare entrepreneur who invested in Brellium, contributing industry knowledge and strategic insights.
Steve Gutentag, co-founder of Thirty Madison, is an individual investor whose experience in digital health helps Brellium refine its approach to healthcare compliance.
Demitri Karagas, also co-founder of Thirty Madison, invested in Brellium, enhancing the company’s connections within the digital health ecosystem.
Cory Levy, founder of Z Fellows, invested in Brellium, bringing expertise in building early-stage technology ventures.
Fiat Ventures is an investment firm focusing on early-stage technology companies and supports Brellium’s expansion and operational growth.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Brellium Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.